Showing results (1-10 of 381) with videos related to
Sort By:
Pageof 39
Journal of Clinical Pharmacology|September 26, 2019
The Case for an Unblinded Modeler in Early Clinical DevelopmentAndreas Krause, Andrea Henrich, Jasper DingemanseCPT: Pharmacometrics & Systems Pharmacology|May 6, 2021
Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonistsAndrea Henrich, Christian Hove Claussen, Jasper Dingemanse, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 3, 2021
PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QTAndrea Henrich, Pierre-Eric Juif, Jasper Dingemanse, et al.Clinical Drug Investigation|July 31, 2021
Impact of Daridorexant, a Dual Orexin Receptor Antagonist, on Cardiac Repolarization Following Bedtime Dosing: Results from a Thorough QT Study Using Concentration-QT AnalysisUta Schilling, Andrea Henrich, Clemens Muehlan, et al.Biomolecules|September 28, 2023
Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor AntagonistsChih-Hsuan Hsin, Jasper Dingemanse, Andrea Henrich, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 25, 2017
Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug developmentJasper Dingemanse, Andreas KrausePharmaceutics|October 11, 2016
Drug Development for Pediatric Populations: Regulatory AspectsJochen Zisowsky, Andreas Krause, Jasper DingemansePulmonary Pharmacology & Therapeutics|March 5, 2018
Modeling of pharmacokinetics, efficacy, and hemodynamic effects of macitentan in patients with pulmonary arterial hypertensionAndreas Krause, Jochen Zisowsky, Jasper DingemanseJournal of Clinical Pharmacology|July 14, 2020
Estimation of Attainment of Steady-State Conditions for Compounds With a Long Half-LifeAndreas Krause, Dominik Lott, Jasper DingemanseJournal of Dermatological Science|November 28, 2017
Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasisAndreas Krause, Daniele D'Ambrosio, Jasper DingemansePageof 39